Altamira Therapeutics Ltd. Actuarial Gains Losses Arising From Changes In Demographic Assumptions Net Defined Benefit Liability Asset
Altamira Therapeutics Ltd. (CYTOF) reported Actuarial Gains Losses Arising From Changes In Demographic Assumptions Net Defined Benefit Liability Asset of -CHF 3.90 thousand for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Income Statement › Other Income
ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset · last filed 2025-04-30
CHF
| Period end | Actuarial Gains Losses Arising From Changes In Demographic Assumptions Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2023-12-31 | -3.90K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | -229.11K CHF 20-F/A · filed 2024-04-22 |
| 2018-12-31 | 0.00 CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 0.00 CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 258.88K CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 0.00 CHF 20-F · filed 2018-03-22 |
USD
| Period end | Actuarial Gains Losses Arising From Changes In Demographic Assumptions Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2023-12-31 | $4.35K 20-F · filed 2025-04-30 |